Cervical lymph node dissection in papillary thyroid cancer: Current trends, persisting controversies, and unclarified uncertainties

Surgical Oncology

Volumn 19, Issue 2, 2010, Pages

  Sakorafas, George H ^a   Sampanis, Dimitrios ^a   Safioleas, Michael ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Complications; Differentiated thyroid cancer; Lymph node metastases; Micrometastases; Node dissection; Papillary; Recurrence; Surgery; Survival; Thyroid; Thyroidectomy

Indexed keywords

LEVOTHYROXINE; RADIOACTIVE IODINE; THYROTROPIN;

BIOLOGICAL ACTIVITY; CANCER PREVENTION; CANCER SURVIVAL; CERVICAL LYMPH NODE; CERVICAL LYMPHADENOPATHY; ELECTIVE SURGERY; HORMONE INHIBITION; HUMAN; HYPOPARATHYROIDISM; INCISION; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDICAL DOCUMENTATION; MICROMETASTASIS; NECK DISSECTION; NEUROPATHIC PAIN; PARATHYROID GLAND; PATIENT CARE PLANNING; PATIENT SAFETY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUALITY OF LIFE; RADIOISOTOPE THERAPY; RECURRENT CANCER; RECURRENT LARYNGEAL NERVE PALSY; REVIEW; SENTINEL LYMPH NODE; SHOULDER INJURY; SURGICAL ANATOMY; SURGICAL APPROACH; THORAX INJURY; THYROID CANCER; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

ADENOCARCINOMA, PAPILLARY; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY; THYROID NEOPLASMS; THYROIDECTOMY; THYROTROPIN; UNCERTAINTY;

EID: 77952550332     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2009.04.002     Document Type: Review

References (126)

1. Gosnell J.E., and Clark O.H. Surgical approaches to thyroid tumors. Endocrinol Metab Clin North Am 37 (2008) 437-455
2. Hundahl S.A., Cady B., Cunningham M.P., et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. U.S. and German Thyroid Cancer Study Group. Cancer 89 (2000) 202-217
3. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M. Cancer statistics. CA Cancer J Clin 57 (2007) 43-66
4. Cooper D.S., Doherty G.M., Haugen B.R., Kloos R.T., Lee S.L., Mandel S.J., et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16 (2006) 109-142
5. Tisell L.E., Nilsson B., Molne J., Hansson G., Fjalling M., Jansson S., et al. Improved survival of patients with papillary thyroid cancer after surgical microdissection. World J Surg 20 (1996) 854-859
6. Kupferman M.E., Patterson M., Mandel S.J., LiVolsi V., and Weber R.S. Patterns of lateral neck metastasis in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 130 (2004) 857-860
7. Sivanandan R., and Soo K.C. Pattern of cervical lymph node metastases from papillary carcinoma of the thyroid. Br J Surg 88 (2001) 1241-1244
8. Shaha A.R., Shah J.P., and Loree T.R. Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid. Am J Surg 172 (1996) 692-694
9. Kelemen P.R., Van Herle A.J., and Giuliano A.E. Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg 133 (1998) 288-292
10. Dixon E., McKinnon J.G., and Pasieka J.L. Feasibility of sentinel lymph node biopsy and lymphatic mapping in nodular thyroid neoplasms. World J Surg 24 (2000) 1396-1401
11. Fukui Y., Yamakawa T., Taniki T., Numoto S., Miki H., and Monden Y. Sentinel lymph node biopsy in patients with papillary thyroid carcinoma. Cancer 92 (2001) 2868-2874
12. Arch-Ferrer J., Velazquez D., Fajardo R., Gamboa-Dominguez A., and Herrera M.F. Accuracy of sentinel lymph node in papillary thyroid carcinoma. Surgery 130 (2001) 907-913
13. Pelizzo M.R., Boschin I.M., Toniato A., Bernante P., Piotto A., Rinaldo A., et al. The sentinel node procedure with Patent Blue V dye in the surgical treatment of papillary thyroid carcinoma. Acta Otolaryngol 121 (2001) 421-424
14. Dzodic R., Markovic I., Inic M., Jokic N., Djurisic I., Zegarac M., et al. Sentinel lymph node biopsy may be used to support the decision to perform modified radical neck dissection in differentiated thyroid carcinoma. World J Surg 30 (2006) 841-846
15. Wada N., Duh Q.Y., Sugino K., Iwasaki H., Kameyama K., Mimura T., et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 237 (2003) 399-407
16. Sakorafas G.H., Giotakis J., and Stafyla V. Papillary thyroid microcarcinoma: a surgical perspective. Cancer Treat Rev 31 (2005) 423-438
17. Hubert Jr. J.P., Kiernam P.D., and Beahrs O.H. Occult papillary carcinoma of the thyroid. Arch Surg 115 (1980) 394-396
18. Grant C.S., and van Heerden J.A. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112 (1992) 1139-1145
19. Chow S.M., Lay S.C., Chan J.K., Au S.K., Yau S., and Lau W.H. Papillary microcarcinoma of the thyroid-prognostic significance of lymph node metastasis and multifocality. Cancer 98 (2003) 31-40
20. Ito Y., Tomoda C., Uruno T., Takamura Y., Miya A., Kobayashi K., et al. Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg 30 (2006) 91-99
21. Gulben K., Berberoglu U., Celen O., and Mersin H.H. Incidental papillary microcarcinoma of the thyroid-factors affecting lymph node metastasis. Langenbecks Arch Surg 393 (2008) 25-29
22. Lee S.H., Lee S.S., Jin S.M., Kim J.H., and Rho Y.S. Predictive factors for central compartment lymph node metastasis in thyroid papillary microcarcinoma. Laryngoscope 118 (2008) 659-662
23. Seigel R.J. Surgical pathology of lymph nodes in cancer staging: routine and specialized techniques. Surg Oncol Clin N Am 5 1 (1996) 25-31
24. Qubain S.W., Nakano S., Baba M., Takao S., and Aikou T. Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery 131 (2002) 249-256
25. Cranshaw I.M., and Carnaille B. Micrometastases in thyroid cancer. An important finding?. Surg Oncol 17 (2008) 253-258
26. Cranshaw I.M., Jany T., Arnalsteen L., Pattou F., and Carnaille B. Significance of lymph node micrometastases in papillary thyroid carcinoma. ANZ J Surg 77 Suppl. 1 (2007) A21
27. Shaha A.R., Shah J., and Loree T.R. Patterns of failure in differentiated carcinoma of the thyroid based on risk groups. Head Neck 20 (1998) 26-30
28. Grebe S.K., and Hay I.D. Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. Surg Oncol Clin N Am 5 (1996) 43-63
29. Harwood J., Clark O.H., and Dunphy J.E. Significance of lymph node metastasis in differentiated thyroid cancer. Am J Surg 136 (1978) 107-112
30. Mazzaferri E.L., and Young R.L. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 70 (1981) 511-518
31. McHenry C.R., Rosen I.B., and Walfish P.G. Prospective management of nodal metastases in differentiated thyroid cancer. Am J Surg 162 (1991) 353-356
32. McCohaney W.M., Hay I.D., Woolner L.B., van Heerden J.A., and Taylor W.F. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic finding, therapy, and outcome. Mayo Clin Proc 61 (1986) 978-996
33. Mazzaferri E.L. Papillary thyroid carcinoma: factors influencing prognosis and current therapy. Semin Oncol 14 (1987) 315-332
34. Akslen L.A. Prognostic importance of histologic grading in papillary thyroid carcinoma. Cancer 72 (1993) 2680-2685
35. Wada N., Suganuma N., Nakayama H., Masudo K., Rino Y., Masuda M., et al. Microscopic regional lymph node status in papillary thyroid carcinoma with and without lymphadenopathy and its relation to outcomes. Langenbecks Arch Surg 392 (2007) 417-422
36. Hughes C.J., Shaha A.R., Shah J.P., and Loree T.R. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck 18 (1996) 127-132
37. Sugino K., Kure Y., Iwasaki H., Ozaki O., Mimura T., Matsumoto A., et al. Metastases to the regional lymph nodes, lymph node recurrence, and distant metastases in nonadvanced papillary thyroid carcinoma. Surg Today 25 (1995) 324-328
38. Cady B., and Rossi R. An expanded view of the risk-group definition in differentiated thyroid carcinoma. Surgery 104 (1988) 947-953
39. Mazzeferri E.L., and Jhiang S.M. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97 (1994) 418-428
40. Hay I.D., Bergstralh E.J., Goellner J.R., Ebersold J.R., and Grant C.S. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114 (1993) 1050-1058
41. Kukkonen S.T., Haapiainen R.K., Rranssila K.O., and Sivula A.H. Papillary thyroid carcinoma: the new, age-related TNM classification system in a retrospective analysis of 199 patients. World J Surg 14 (1990) 837-842
42. Ito Y., Higashiyama T., Takamura T., Miya A., Kobayashi K., Matsuzuka F., et al. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J Surg 31 (2007) 2085-2091
43. Lundgren C.I., Hall P., Dickman P.W., and Zedenius J. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 106 (2006) 524-531
44. Scheumann G.F., Gimm O., Wegener G., Hundeshagen H., and Dralle H. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 18 (1994) 559-568
45. Ohshima A., Yamashita H., Noguchi S., Uchino S., Watanabe S., Toda M., et al. Indications for bilateral modified radical neck dissection in patients with papillary carcinoma of the thyroid. Arch Surg 135 (2000) 1194-1199
46. Yamashita H., Noguchi S., Murakami N., Kawamoto H., and Watanabe S. Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma. Cancer 80 12 (1997) 2268-2272
47. Rossi R.L., Cady B., Silverman M.L., Wool M.S., and Horner T.A. Current trends of conservative surgery for differentiated thyroid carcinoma. World J Surg 10 (1986) 612-622
48. DeGroot L.J., Kaplan E.L., McCormick M., and Straus F.H. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71 (1990) 414-424
49. Byar D.P., Green S.B., Dor P., Williams E.D., Colon J., van Gilse H.A., et al. A prognostic index for thyroid carcinoma: a study of the E.O.R.T.C. thyroid cancer cooperative group. Eur J Cancer 15 (1979) 1033-1041
50. Bhattacharyya N. Surgical treatment of cervical nodal metastases in patients with papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 129 (2003) 1101-1104
51. Bhattacharyya N. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma. Otolaryngol Head Neck Surg 128 (2003) 115-123
52. Sugitani I., Kasai N., Fujimoto Y., and Yanagisawa A. A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 135 (2004) 139-148
53. Noguchi S., Murakami N., Yamashita H., Toda M., and Kawamoto H. Papillary thyroid carcinoma: modified radical neck dissection improves prognosis. Arch Surg 133 (1998) 276-281
54. Simon D., Goretzki P.E., Witte J., and Roher H.D. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg 20 (1996) 860-866
55. Lee Y.S., Kim S.W., Kim S.W., et al. Extent of routine central lymph node dissection with small papillary thyroid carcinoma. World J Surg 31 (2007) 1954-1959
56. Esnaola N.F., Cantor S.B., Sherman S.I., Lee J.E., and Evans D.B. Optimal treatment strategy in patients with papillary thyroid cancer: a decision analysis. Surgery 130 (2001) 921-930
57. Grubbs E.G., Rich T.A., Li G., Sturgis E.M., Younes M.N., Myers J.N., et al. Recent advances in thyroid cancer. Curr Probl Surg 45 (2008) 156-250
58. Grodski S., Cornford L., Sywak M., Sidhu S., and Delbridge L. Routine level VI lymph node dissection for papillary thyroid cancer: surgical technique. ANZ J Surg 77 (2007) 203-208
59. Ying M., and Ahuja A. Sonography of neck lymph nodes. Part I: normal lymph nodes. Clin Radiol 58 (2003) 351-358
60. Fish S.A., Langer J.E., and Mandel S.J. Sonographic imaging of thyroid nodules and cervical lymph nodes. Endocrinol Metab Clin North Am 37 (2008) 401-417
61. Som P.M., Curtin H.D., and Mancuso A.A. An imaging-based classification for the cervical nodes designed as an adjunct to recent clinically based nodal classifications. Arch Otolaryngol Head Neck Surg 125 (1999) 388-396
62. Robbins K.T., Clayman G., Levine P.A., Medina J., Sessions R., Shaha A., et al. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology - Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 128 (2002) 751-758
63. Shaha A.R. Management of the neck in thyroid cancer. Otolaryngol Clin North Am 31 (1998) 823-831
64. Roh J.L., Kim J.M., and Park C.I. Lateral cervical lymph node metastases from papillary thyroid carcinoma: pattern of nodal metastases and optimal strategy for neck dissection. Ann Surg Oncol 15 (2008) 1177-1182
65. Lee J., Sung T.Y., Nam K.H., Chung W.Y., Soh E.Y., and Park C.S. Is level IIb lymph node dissection always necessary in N1b papillary thyroid carcinoma patients?. World J Surg 32 (2008) 716-721
66. Shah J.P. Cervical lymph node metastases-diagnostic, therapeutic and prognostic implications. Oncology 4 (1990) 61-69
67. Caron N.R., Tan Y.Y., Ogivlie J.B., Triponez F., Reiff E.S., Kebebew E., et al. Selective modified radical neck dissection for papillary thyroid cancer-is level I, II and V dissection always necessary?. World J Surg 30 (2006) 833-840
68. Gimm O., Rath F.W., and Dralle H. Pattern of lymph node metastases in papillary thyroid carcinoma. Br J Surg 85 (1998) 252-254
69. Roh J.L., Park J.Y., and Park C.I. Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg 245 (2007) 604-610
70. Machens A., Hinze R., Thomusch O., and Dralle H. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 26 (2002) 22-28
71. Noguchi S., Noguchi A., and Murakami N. Papillary carcinoma of the thyroid. I. Developing pattern of metastasis. Cancer 26 (1970) 1053-1060
72. Mirallie E., Visset J., Sagan C., Hamy A., Le Bodic M.F., and Paineau J. Localization of cervical node metastasis of papillary thyroid carcinoma. World J Surg 23 (1999) 970-974
73. Machens A., Holzhausen H.J., and Dralle H. Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch Surg 139 (2004) 43-45
74. Robbins K.T., Atkinson J., Byers R.M., Cohen J.I., Lavertu P., and Pellitteri P. The use and misuse of neck dissection for head and neck cancer. J Am Coll Surg 193 (2001) 91-102
75. Byers R.M. Neck dissection: concepts, controversies, and technique. Semin Surg Oncol 7 (1991) 9-13
76. Shaha A.R. Complications of neck dissection for thyroid cancer. Ann Surg Oncol 15 (2008) 397-399
77. Musacchio M.J., Kim A.W., Vijungco J.D., and Prinz R.A. Greater local recurrence occurs with 'berry picking' than neck dissection in thyroid cancer. Am Surg 69 (2003) 191-196
78. Palazzo F.F., Gosnell J., Savio R., Reeve T.S., Sidhu S.B., Sywak M.S., et al. Lymphadenectomy for papillary thyroid cancer: changes in practice over four decades. Eur J Surg Oncol 32 (2006) 340-344
79. Tuttle R.M., Loboeuf R., and Martorella A.J. Papillary thyroid cancer: monitoring and therapy. Endocrinol Metab Clin North Am 36 (2007) 753-778
80. Noguchi M., Kumaki T., Taniya T., and Miyazaki I. Bilateral cervical lymph node metastases in well differentiated thyroid cancer. Arch Surg 125 (1990) 804-806
81. Henry J.F., Gramatica L., Denizot A., Kvachenyuk A., Puccini M., and Defechereux T. Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma. Langenbecks Arch Surg 383 (1998) 167-169
82. Noguchi M., Earashi M., Kitagawa H., Ohta N., Thomas M., Miyazaki I., et al. Papillary thyroid cancer and its surgical management. J Surg Oncol 49 (1992) 140-149
83. Thyroid carcinoma. Available from:. Clinical practice guidelines in oncology vol 2007 (2007), National Comprehensive Cancer Network, Inc. http://www.nccn.rg/professionals/physician_gls/PRF/thyroid.pdf Version 2.2007
84. Pacini F., Schlumberger M., Dralle H., Ilisea R., Smith Y., and Viersinga V. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154 (2006) 787-803
85. Shimamoto K., Satake H., Sawaki A., Ishigaki T., Funahashi H., and Imai T. Preoperative staging of thyroid papillary carcinoma with ultrasonography. Eur J Radiol 29 (1998) 4-10
86. Solorzano C.C., Carneiro D.M., Ramirez M., Lee T.M., and Irvin G.L. Surgeon-performed ultrasound in the management of thyroid malignancy. Am Surg 70 (2004) 576-582
87. Kupferman M.E., Weinstock Y.E., Santillan A.A., Mishra A., Roberts D., Clayman G.L., et al. Thyroid. Townsend: Sabiston textbook of Surgery. 18th ed (2007), Elsevier-Saunders, Philadelphia 707-745
88. Kupferman M.E., Weinstock E.Y., Santillan A.A., et al. Predictors of level V metastasis in well-differentiated thyroid cancer. Head Neck 30 (2008) 1469-1474
89. BTA. British Thyroid Association and Royal College of Physicians: guidelines for the management of thyroid cancer in adults. Available at: (2002). www.british-thyroid-association.org
90. Roher H.D., Simon D., and Goretzki P.E. Guidelines in oncologic surgery - malignant thyroid tumours. Lang Arch Chir Kongressbd 114 (1997) 142-145
91. Sywak M., Cornford L., Roach P., Stalberg P., Sidhu S., and Delbridge L. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 140 (2006) 1000-1005
92. Son Y.I., Jeong H.S., Baek C.H., Chung M.K., Ryu J., Chung J.H., et al. ThyroidCarcinomaTaskForce. AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology. Endocr Pract 7 (2001) 202-220
93. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Thyroid carcinoma. Version 2. Available at: (2007). http://www.nccn.org/professionals/physician_gls/PDF/thyroid.pdf
94. Son Y.-I., Jeong H.-S., Baek C.-H., et al. Extent of prophylactic lymph node dissection in the central neck area of the patients with papillary thyroid carcinoma: comparison of limited versus comprehensive lymph node dissection in a 2-year safety study. Ann Surg Oncol 15 (2008) 2020-2026
95. Kim J.M., Kim T.Y., Kim W.B., Gong G., Kim S.C., Hong S.J., et al. Lymphovascular invasion is associated with lateral cervical lymph node metastasis in papillary thyroid carcinoma. Laryngoscope 116 (2006) 2081-2085
96. Roh J.L., Kim J.M., and Park C. Central cervical nodal metastasis from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis. Ann Surg Oncol 15 (2008) 2482-2486
97. Shindo M., Wu J.C., Park E.E., and Tanzella F. The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer. Arch Otolaryngol Head Neck Surg 132 (2006) 650-654
98. Cheah K., Arici C., Ituarte P.H., Siperstein A.E., Duh O.Y., and Clark O.H. Complications of neck dissection for thyroid cancer. World J Surg 26 (2002) 1013-1016
99. Dijkstra P.U., van Wilgen P.C., Buijs R.P., Brendeke W., de Goede C.J., Kerst A., et al. Incidence of shoulder pain after neck dissection: a clinical explorative study for risk factors. Head Neck 23 (2001) 947-953
100. Cheng P.T., Hao S.P., Lin Y.H., and Yeh A.R. Objective comparison of shoulder dysfunction after three neck dissection techniques. Ann Otol Rhinol Laryngol 109 (2000) 761-766
101. Cappiello J., Piazza C., Giudice M., DeMaria G., and Nicolai P. Shoulder disability after different selective neck dissections (levels II-IV versus levels II-V): a comparative study. Laryngoscope 115 (2005) 259-263
102. Kuntz A.L., and Weymuller Jr. E.A. Impact of neck dissection on quality of life. Laryngoscope 109 (1999) 1334-1338
103. Scheumann G.F., Seeliger H., Musholt T.F., Gimm O., Wegener G., Dralle H., et al. Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma. Eur J Surg 162 (1996) 677-684
104. Terrell J.E., Welsh D.E., Bradford C.R., Chepeha D.B., Esclamado R.M., Hogikyan N.D., et al. Pain, quality of life, and spinal accessory nerve status after neck dissection. Laryngoscope 110 (2000) 620-626
105. Inoue H., Nibu K., Saito M., Otsuki N., Ishida H., Onitsuka T., et al. Quality of life after neck dissection. Arch Otolaryngol Head Neck Surg 132 (2006) 662-666
106. van Wilgen C.P., Dijkstra P.U., van der Laan B.F., Plukker J.T., and Roodenburg J.L. Shoulder complaints after neck dissection; is the spinal accessory nerve involved?. Br J Oral Maxillofac Surg 41 (2003) 7-11
107. Sobol S., Jensen C., Sawyer W., Costiloe P., and Thong N. Objective comparison of physical dysfunction after neck dissection. Am J Surg 150 (1985) 503-509
108. Miccoli P., Materazzi G., and Berti P. Minimally invasive video-assisted lateral lymphadenectomy: a proposal. Surg Endosc 22 (2008) 1131-1134
109. Lombardi C.P., Raffaelli M., Princi P., De Crea C., and Bellantone R. Minimally invasive video-assisted functional lateral neck dissection for metastatic papillary thyroid carcinoma. Am J Surg 193 (2007) 114-118
110. Sakorafas G.H., and Peros G. Sentinel lymph node biopsy in breast cancer; what a clinician should know, a decade after its introduction in clinical practice. Eur J Cancer Care 16 (2007) 318-321
111. Ariyan C.E., and Coit D.G. Clinical aspects of sentinel lymph node biopsy in melanoma. Sem Diagn Pathol 25 (2008) 86-94
112. Roh J.-L., and Park C. Sentinel lymph node biopsy as guidance for central neck dissection in patients with papillary thyroid carcinoma. Cancer 113 (2008) 1527-1531
113. Rubello D., Pelizzo M.R., Al-Nahhas A., Salvatori M., O'Doherty M.J., Guiliano A.E., et al. The role of sentinel lymph node biopsy in patients with differentiated thyroid carcinoma. Eur J Surg Oncol 32 (2006) 917-921
114. Pujol P., Daures J.P., Nsakala N., Baldet L., Bringer J., and Jaffiol C. Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. J Clin Endocrinol Metab 81 (1996) 4318-4323
115. McGriff N.J., Csako G., Gourgiotis L., Lori C.G., Pucini F., and Sarlis N.J. Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer. Ann Med 34 (2002) 554-564
116. Biondi B., Filetti S., and Schlumberger M. Thyroid-hormone therapy and thyroid cancer: a reassessment. Nat Clin Pract Endocrinol Metab 1 1 (2005) 32-40
117. Haugen B.R., Pacini F., Reiners C., Schlumberger M., Ladenson P.W., Sherman S.I., et al. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 84 (1999) 3877-3885
118. Burmeister L.A., Goumaz M.O., Mariash C.N., and Oppenheimer J.H. Levothyroxine dose requirements for thyrotropin suppression in the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab 75 (1992) 344-350
119. Sun L., Davies T.F., Blair H.C., Abe E., and Zaidi M. TSH and bone loss. Ann N Y Acad Sci 1068 (2006) 309-318
120. Sawin C.T., Geller A., Wolf P.A., Belanger A.J., Baker E., Bacharach P., et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331 (1994) 1249-1252
121. Parle J.V., Maisonneuve P., Sheppard M.C., Boyle P., and Franklyn J.A. Prediction of all-cause and cardiovascular mortality in elderly people from one low-serum thyrotropin result: a 10-year cohort study. Lancet 358 (2001) 861-865
122. Surks M.I., Ortiz E., Daniels G.H., Sawin C.T., Col N.F., Cobin R.H., et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291 (2004) 228-238
123. Tubiana M., Perez R., Parmentier C., and Monnier J.P. The survival of patients with thyroid cancers treated with radioactive iodine. Apropos of 147 cases followed up for more than 5 years. Presse Med 76 (1968) 1999-2002
124. Hay I.D., Thompson G.B., Grant C.S., Bergstralh E.J., Dvorak C.E., Gorman C.A., et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 26 (2002) 879-885
125. Sawka A.M., Thephamongkhol K., Brouwers M., Thabane L., Browman G., and Gerstein H.C. Clinical review 170: a systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer. J Clin Endocrinol Metab 89 (2004) 3668-3676
126. Hay I.D., McConahey W.M., and Goellner J.R. Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinic's experience of treating 2512 consecutive patients during 1940 through 2000. Trans Am Clin Climatol Assoc 113 (2002) 241-260